Jubilant Pharmova announced that India Ratings and Research has assigned Long-term issuer rating of 'IND AA+' Rating for Jubilant Pharmova. The instrument-wise ratings are given below:
Fund-based working capital limits (Rs 100 crore) - IND AA+/Stable/ IND A1+
Non-fund-based working capital limits (Rs 150 crore) - IND A1+
Proposed commercial paper programme (Rs 100 crore) - IND A1+
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
